The bad news is the paper, the good news is most doctors and journalists don't read the scholarly literature and are never going to read this.
Dr Pierre Tattevin is the president of the French Society of Infectious Pathology (SPILF), which scientific journalists in France generally side with. For example, last year, Dr Tattevin was
invited to talk at a panel run by a popular YouTube channel that promotes critical thinking and scientific skepticism.
SPILF have historically had a tough stance against chronic Lyme, and people with PTLDS have heavily criticized them for it. Notably, when the French High Authority of Health (HAS) published guidelines for the diagnosis & treatment of chronic Lyme in 2018-19 (?), SPILF refused to endorse them and released their own different recommendations shortly afterwards. Most French doctors seem to apply the latter now.
Whether there is a chronic infection or not, it's sad for PTLDS patients and science that none of the French scientific skeptics criticize the thinking that it must be a functional somatic syndrome because the underlying biological cause(s) has (have) not been identified yet. The BPS model is widely popular in French medicine especially for chronic pain and fibromyalgia, and I admit it really weirds me out that "no fake med" doctors/EBM supporters buy it (because its scientific basis is nil). I suppose they're simply not very interested in looking into illnesses considered as FSS or MUS. But instead of going down the easy, unscientific posture of psychosomatic symptoms, they should simply state things as they are: the pathophysiology of PTLDS is not understood at the biomolecular level.
On the other hand, SPILF play an important role in calling out and pushing back against notorious Lyme quacks who harm patients through dubious treatments. First and foremost
Dr Christian Perronne and his network of Lyme quack doctors dubbed Chronimed. Among other things, these people prescribe long-term antibiotics courses, or artemisia, or hydroxychloroquine w/ azithromiticin for autistic children.
Eventually, as is the case elsewhere in the world, PTLDS patients in France end up without recognition and medical care most of the time. It's completely understandable that they then fall for promises of better health from these quacks, but they shouldn't be the ones to be blamed. The president of SPILF certainly shouldn't partake in doing so by publishing a paper like this one.